Please ensure Javascript is enabled for purposes of website accessibility
Home > Featured Products > Bacteria & Viruses-related products > Hantaan Virus (HTNV, HV)

Research-grade reagents for Hantaan Virus (HTNV) — the prototypical species of the genus Hantavirus (family Bunyaviridae, order Bunyavirales), an enveloped, negative-sense, tri-segmented RNA virus. HTNV is the causative agent of hemorrhagic fever with renal syndrome (HFRS), a severe rodent-borne zoonotic disease endemic to East Asia (particularly China, Korea, Russia) with up to 15% case fatality rate and acute kidney injury as the defining clinical feature. The viral envelope is anchored by two surface glycoproteins cleaved from a single polyprotein precursor: Gc (glycoprotein C, ~67 kDa, receptor-binding protein) and Gn (glycoprotein N, ~48 kDa, membrane fusion protein). Together, Gc and Gn form the functional entry complex and are the principal targets for neutralizing antibody responses. The nucleoprotein (N protein) is the major structural component of the helical ribonucleoprotein complex and a diagnostic marker for acute infection. We offer recombinant antibodies, InVivoMAb broad-neutralizing functional-grade antibodies, and recombinant proteins targeting Gc, Gn, and N protein, validated for ELISA, Western blot, neutralization, and immunoprecipitation. Comprehensive coverage of envelope glycoproteins and structural proteins supports serodiagnostic assay development, viral entry mechanism studies, broadly neutralizing antibody discovery, pseudovirus neutralization screening, vaccine immunogenicity testing, and HFRS pathogenesis research. RUO

Recombinant Antibodies A focused panel of sequence-defined clones targeting both major envelope glycoproteins: Gc/GP (clones 3G1, A5) which mediate initial receptor engagement and endocytic uptake, and Gn/G1 (clones AH100, SAA2516) which drive the membrane fusion process. This complementary two-protein targeting strategy enables epitope mapping across the fusion mechanism, competitive binding studies to elucidate the Gc-Gn functional interaction, and entry inhibitor screening. Suitable for pseudovirus neutralization assays and antigen-specific immune response characterization.
InVivoMAb Broad-Neutralizing Antibodies Low-endotoxin, azide-free neutralizing antibodies targeting Gc glycoprotein (clones Iv0260, Iv0261), designated as broad-neutralizing due to their potent cross-protective activity in vivo. Validated for passive immunization, viral challenge protection, and functional blocking of viral entry. These clones are particularly valuable for studying Gc-directed neutralization mechanisms and evaluating Gc-based vaccine immunogenicity across diverse HTNV strains and related hantavirus species.
Recombinant Proteins His-tagged and Fc-fused HTNV antigens covering glycoprotein N/Gn (Gn/G1 domain, available in both His and Fc formats) and nucleoprotein N (His-tagged). The Fc-fusion Gn protein enhances stability and half-life in animal studies, while His-tagged variants are optimized for ELISA coating, immunoprecipitation, and pull-down assays. The nucleoprotein is suitable as a rapid diagnostic antigen for IgM/IgG acute-phase serology development and a cross-reactive marker for hantavirus genus-level screening.

All products manufactured by AtaGenix Laboratories under ISO 9001 & ISO 13485 quality systems.

References

1. Vaheri A, Strandin T, Hepojoki J, et al. Uncovering the mystery of hantavirus infection. Nat Rev Microbiol. 2013;11(8):539-550. DOI

2. Strandin T, Hepojoki J, Vaheri A. Cytoplasmic tails of bunyavirus Gn glycoproteins—could they act as matrix protein surrogates? Virology. 2013;437(2):73-80. DOI

3. Mackow ER, Gavrilovskaya IN. Hantavirus regulation of endothelial cell barrier function. Curr Top Microbiol Immunol. 2010;338:157-173. DOI

4. Outinen TK, Laine OK, Makela SM, et al. Characterization of systemic innate immune response in hemorrhagic fever with renal syndrome patients. PLoS ONE. 2016;11(6):e0157584. DOI

14 product results for "Hantaan Virus (HTNV, HV)"

Options+
Options
Confirm
  • Product types
    0 selected
    Antibodies (8)
    Research Biosimilar (3)
    Proteins (3)
  • Expression system
    0 selected
    Mammalian Cells (3)
    E. coli (3)
  • Target
    0 selected
    GP/Envelopment polyprotein (5)
    GP/Envelope Glycoprotein Gc (1)
    Glycoprotein C/Gc (4)
    Glycoprotein N/Gn (2)
    N/Nucleoprotein (2)
  • Species
    0 selected
    Hantaan virus (HTNV) (2)
    Black Creek Canal orthohantavirus (BCCV) (3)
    Puumala virus (PUUV) (2)
    Dobrava-Belgrade virus (DOBV) (2)
    Seoul virus (SEOV) (2)
    Andes virus (ANDV) (2)
    Sin Nombre virus (SNV) (2)
    Orthohantavirus puumalaense (PUUV) (4)
  • Applications
    0 selected
    IF (1)
    Research in vivo (3)
    SDS-PAGE (3)
    Immunogen (3)
    WB (7)
    ELISA (14)
    Bioactivity testing in progress (3)
    IHC (3)
    Bioactivity: FACS (3)
    FCM (1)
    Functional assay (3)
    Neutralization (3)
  • Reactivity
    0 selected
    Black Creek Canal orthohantavirus (BCCV) (3)
    Hantaan virus (HTNV) (4)
    Puumala virus (PUUV) (2)
    Dobrava-Belgrade virus (DOBV) (2)
    Seoul virus (SEOV) (2)
    Andes virus (ANDV) (2)
    Puumala virus (4)
    Sin Nombre virus (SNV) (2)
  • Host species
    0 selected
    Rabbit (3)
    Human (8)
  • Clonality
    0 selected
    Monoclonal (8)
    Polyclonal (3)
  • Conjugate
    0 selected
    Unconjugated (8)